Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 1 week TORONTO, April 07, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical compan…
Author of the article:
Article content
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 1 week
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) A…